Metabolic management of ischaemic heart disease
- 1 November 1993
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 14 (suppl G) , 2-5
- https://doi.org/10.1093/eurheartj/14.suppl_g.2
Abstract
The present review summarizes the available information on the effects of the three major classes of antianginal agents (nitrates, calcium and beta-blockers) on myocardial energy metabolism. It also discusses the role of some new molecules (L-carnitine, trimetazidine and ranolazine) that have been proposed as an alternative pharmacological approach for the metabolic management of cardiac ischaemic syndromes.Keywords
This publication has 0 references indexed in Scilit: